Pituitary adenylate cyclase-activating polypeptide-38 (PACAP38), an endogenous neuropeptide, is a promising target for treating migraine headache because increased PACAP38 levels are closely related to the onset of migraine [4–7]. Here, ADCYAP1 is linked to migraine disorder.